• Latest Posts
Opinion 1 Nov 2023

Could this be the start of a new era for PI3K drugs?

FDA approves Beyfortus ahead of 2023-24 RSV season

AstraZeneca non-small cell lung cancer drug meets primary endpoint

SandboxAQ launches new division to boost drug development

Quell in potential $2B AstraZeneca cell therapy deal

Podcast 26 May 2023

Beyond Biotech podcast 47

World’s first RSV vaccine for older adults gets FDA approval

AstraZeneca creates FRAGLER for DNA synthesis

Ibex to collaborate with AstraZeneca and Daiichi Sankyo on AI breast cancer product

Beyond Biotech podcast 30: Advanced Therapies Congress, BioAlps, Bionter, C2i Genomics 

AstraZeneca’s Airsupra gets US approval as new rescue treatment for asthma